Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Alemtuzumab Safe, Effective First-Line Treatment for Chronic Lymphocytic Leukemia
Link ID 1914
Title Alemtuzumab Safe, Effective First-Line Treatment for Chronic Lymphocytic Leukemia
Url http://www.medscape.com/viewarticle/567960?src=rss
Description Alemtuzumab is superior to chlorambucil as first-line treatment for patients with chronic lymphocytic leukemia (CLL), according to results of a study published in the December issue of the Journal of Clinical Oncology. Reuters Health Information
Category Articles > Pharmacists
Keywords
Date Dec 27, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. Sirolimus Stents Better at Reducing Restenosis
  Sirolimus-eluting stents may offer an advantage over bare-metal stents in patients with ST segment elevation myocardial infarction (STEMI), Dutch researchers report in the February 12th issue of the Journal of the American College of Cardiology. Reuters Health Information
Category:   Articles > Pharmacists


2. Statin Pretreatment Improves Myocardial Perfusion After Primary Angioplasty
  Among patients with acute myocardial infarction (AMI), prior statin therapy is associated with better perfusion after primary angioplasty of the infarct-related artery, according to a report in the January 15 issue of the American Journal of Cardiology. Reuters Health Information
Category:   Articles > Pharmacists


3. Sorafenib Active Against Hormone-Refractory Prostate Cancer
  Sorafenib, an agent with both antiangiogenic and antiproliferative activity, may represent a useful treatment for progressive hormone-refractory prostate cancer, new research suggests. Reuters Health Information
Category:   Articles > Pharmacists


4. Chemotherapy and Tamoxifen Cut Long-Term Risk of Contralateral Breast Cancer
  Adjuvant chemotherapy and tamoxifen treatment for primary breast cancer are both independently associated with reduced risks of contralateral breast cancer that persist for up to 10 and 5 years, respectively, after the first cancer diagnosis, according to a report in the Journal of the National Cancer Institute for January 2. Reuters Health Information
Category:   Articles > Pharmacists


5. Statins May Reduce Risk of Kidney Cancer
  Treatment with statins appears to reduce the risk of renal cell carcinoma, according to the results of a case-control study of nearly 500,000 veterans. Reuters Health Information
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS